Solid Biosciences (SLDB) Interest & Investment Income (2017 - 2026)
Solid Biosciences (SLDB) reported Interest & Investment Income of $2.1 million for Q1 2026, down 10.26% on a YoY basis from $2.3 million in Q1 2025, and up 0.58% sequentially from $2.1 million in Q4 2025.
Solid Biosciences (SLDB) Interest & Investment Income (2017 - 2026) Analysis & Trends
Solid Biosciences (SLDB) has 9 years of Interest & Investment Income data on file, last reported at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 10.26% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (up 1.83% YoY), and the FY2025 full-year result was $9.9 million, up 4.59% from the prior year.
- Interest & Investment Income rose to $2.1 million in Q1 2026, from $2.1 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.6 million in Q3 2025 to a low of -$40000.0 in Q2 2025.
- A 5-year average of $1.2 million and a median of $1.5 million in 2022 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 12205.26% in 2025, while the deepest fall reached 263.64% in 2025.
- Tracing SLDB's Interest & Investment Income over 5 years: stood at $1.5 million in 2022, then climbed by 14.73% to $1.8 million in 2023, then advanced by 9.38% to $1.9 million in 2024, then increased by 6.6% to $2.1 million in 2025, then gained by 0.58% to $2.1 million in 2026.
- Business Quant data shows SLDB's Interest & Investment Income at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Solid Biosciences | 871.35 Mn | 871.35 Mn | - | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | 2.05 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | -40,000.00 |
| Mar 31, 2025 | 2.30 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Dec 31, 2023 | 1.76 Mn |
| Sep 30, 2023 | 1.96 Mn |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 73,000.00 |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 735,000.00 |
| Jun 30, 2022 | 293,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Dec 31, 2020 | 116,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | -2,000.00 |